Compared to warfarin, edoxaban was as effective -- or even more so -- in preventing stroke and blood clots, researchers said.

People on blood thinners have a doubled risk of dangerous internal bleeding if they also take a non-steroidal ...

The study, presented Saturday at a meeting of the American Heart Association in Chicago, is the first large trial to ...

Hello Health Rounds Readers! Today we feature three more studies that were presented at one of the year's most important ...

In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...

The trial included more than 1,200 adults, average age 53, who had AFib but none of the standard risk factors that would necessitate the prescription of blood thinner medication. Half of the study ...

Younger patients with the common heart rhythm disorder atrial fibrillation but no other risk factors for stroke are not likely to benefit from blood-thinning drugs, a Canadian study found.

People using blood thinners to control their heart rhythm shouldn't expect the medications to head off thinking declines as well, new research suggests. The study, presented Saturday at a meeting ...

TUESDAY, Nov. 19, 2024 (HealthDay News) -- Japanese researchers say they have found a pill that works as well as existing medication to prevent blood clots after heart valve surgery, with fewer ...

TUESDAY, Nov. 19, 2024 (HealthDay News) -- People using blood thinners to control their heart rhythm shouldn't expect the medications to head off thinking declines as well, new research suggests.